NeuroSense Therapeutics Cash Flow Statement 2019-2025 | NRSN

Fifteen years of historical annual cash flow statements for NeuroSense Therapeutics (NRSN).

Annual Data | Millions of US $ except per share data

Metric Name
Net Income/Loss
Total Depreciation And Amortization - Cash Flow
Other Non-Cash Items
Total Non-Cash Items
Change In Accounts Receivable
Change In Inventories
Change In Accounts Payable
Change In Assets/Liabilities
Total Change In Assets/Liabilities
Cash Flow From Operating Activities
Net Change In Property, Plant, And Equipment
Net Change In Intangible Assets
Net Acquisitions/Divestitures
Net Change In Short-term Investments
Net Change In Long-Term Investments
Net Change In Investments - Total
Investing Activities - Other
Cash Flow From Investing Activities
Net Long-Term Debt
Net Current Debt
Debt Issuance/Retirement Net - Total
Net Common Equity Issued/Repurchased
Net Total Equity Issued/Repurchased
Total Common And Preferred Stock Dividends Paid
Financial Activities - Other
Cash Flow From Financial Activities
Net Cash Flow
Stock-Based Compensation
Common Stock Dividends Paid
202420232022202120202019
$-10.21$-10.11$-12.34$-4.04$-2.83$-1.22
$0.02$0.02$0.09$0.00$0.00$0
$0.83$-0.18$3.92$2.23$2.06$0.61
$0.86$-0.16$4.00$2.23$2.06$0.61
$-0.75$0.02$0.06$-0.20$-0.01$0.00
$0$0$0$0$0$0
$-0.04$1.89$0.70$0.48$0.08$0.03
$0.01$0.01$0$0$0$0
$-0.78$1.91$0.75$0.27$0.07$0.03
$-10.14$-8.35$-7.59$-1.54$-0.70$-0.58
$0.00$-0.03$-0.07$-0.02$-0.01$-0.01
$0$0$0$0$0$0
$0$0$0$0$0$0
$0$3.50$-3.50$0$0$0
$0.00$0.00$-0.02$0$0$-0.02
$0.00$3.50$-3.52$0$0$-0.02
$0$0$0.05$0$0$0
$0.00$3.47$-3.54$-0.02$-0.01$-0.03
$0$0$0$0$0$0
$0$0$-0.08$0$0$0.00
$0$0$-0.08$0$0$0.00
$11.30$4.34$3.87$11.90$0.51$1.42
$11.30$4.34$3.87$11.90$0.51$1.42
$0$0$0$0$0$0
$-0.39$-0.36$-0.10$0$0$0
$10.91$3.98$3.70$11.90$0.51$1.42
$0.74$-0.90$-7.52$10.36$-0.20$0.81
$0.56$1.54$5.11$4.16$2.06$0.61
$0$0$0$0$0$0